Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 194 entries
Sorted by: Best Match Show Resources per page
Massage therapy and canadians' health care needs 2020: proceedings of a national research priority setting summit.

International journal of therapeutic massage & bodywork

Dryden T, Sumpton B, Shipwright S, Kahn J, Reece BF.
PMID: 24592299
Int J Ther Massage Bodywork. 2014 Mar 04;7(1):3-10. doi: 10.3822/ijtmb.v7i1.228. eCollection 2014 Mar.

BACKGROUND: The health care landscape in Canada is changing rapidly as forces, such as an aging population, increasingly complex health issues and treatments, and economic pressure to reduce health care costs, bear down on the system. A cohesive national...

Cite
Dryden T, Sumpton B, Shipwright S, et al. Massage therapy and canadians' health care needs 2020: proceedings of a national research priority setting summit. Int J Ther Massage Bodywork. 2014;7(1):3-10doi: 10.3822/ijtmb.v7i1.228.
Dryden, T., Sumpton, B., Shipwright, S., Kahn, J., & Reece, B. F. (2014). Massage therapy and canadians' health care needs 2020: proceedings of a national research priority setting summit. International journal of therapeutic massage & bodywork, 7(1), 3-10. https://doi.org/10.3822/ijtmb.v7i1.228
Dryden, Trish, et al. "Massage therapy and canadians' health care needs 2020: proceedings of a national research priority setting summit." International journal of therapeutic massage & bodywork vol. 7,1 (2014): 3-10. doi: https://doi.org/10.3822/ijtmb.v7i1.228
Dryden T, Sumpton B, Shipwright S, Kahn J, Reece BF. Massage therapy and canadians' health care needs 2020: proceedings of a national research priority setting summit. Int J Ther Massage Bodywork. 2014 Mar 04;7(1):3-10. doi: 10.3822/ijtmb.v7i1.228. eCollection 2014 Mar. PMID: 24592299; PMCID: PMC3934855.
Copy Download .nbib Format: NLM
Predicting translation initiation rates for designing synthetic biology.

Frontiers in bioengineering and biotechnology

Reeve B, Hargest T, Gilbert C, Ellis T.
PMID: 25152877
Front Bioeng Biotechnol. 2014 Jan 20;2:1. doi: 10.3389/fbioe.2014.00001. eCollection 2014.

In synthetic biology, precise control over protein expression is required in order to construct functional biological systems. A core principle of the synthetic biology approach is a model-guided design and based on the biological understanding of the process, models...

Cite
Reeve B, Hargest T, Gilbert C, et al. Predicting translation initiation rates for designing synthetic biology. Front Bioeng Biotechnol. 2014;2:1doi: 10.3389/fbioe.2014.00001.
Reeve, B., Hargest, T., Gilbert, C., & Ellis, T. (2014). Predicting translation initiation rates for designing synthetic biology. Frontiers in bioengineering and biotechnology, 21. https://doi.org/10.3389/fbioe.2014.00001
Reeve, Benjamin, et al. "Predicting translation initiation rates for designing synthetic biology." Frontiers in bioengineering and biotechnology vol. 2 (2014): 1. doi: https://doi.org/10.3389/fbioe.2014.00001
Reeve B, Hargest T, Gilbert C, Ellis T. Predicting translation initiation rates for designing synthetic biology. Front Bioeng Biotechnol. 2014 Jan 20;2:1. doi: 10.3389/fbioe.2014.00001. eCollection 2014. PMID: 25152877; PMCID: PMC4126478.
Copy Download .nbib Format: NLM
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Translational behavioral medicine

Bruner DW, Hanisch LJ, Reeve BB, Trotti AM, Schrag D, Sit L, Mendoza TR, Minasian L, O'Mara A, Denicoff AM, Rowland JH, Montello M, Geoghegan C, Abernethy AP, Clauser SB, Castro K, Mitchell SA, Burke L, Trentacosti AM, Basch EM.
PMID: 24073038
Transl Behav Med. 2011 Mar;1(1):110-22. doi: 10.1007/s13142-011-0025-3.

The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminology Criteria for Adverse Events, called the "PRO-CTCAE." The PRO-CTCAE consists of a library of patient-reported items which can be administered in clinical trials to directly...

Cite
Bruner DW, Hanisch LJ, Reeve BB, et al. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med. 2011;1(1):110-22doi: 10.1007/s13142-011-0025-3.
Bruner, D. W., Hanisch, L. J., Reeve, B. B., Trotti, A. M., Schrag, D., Sit, L., Mendoza, T. R., Minasian, L., O'Mara, A., Denicoff, A. M., Rowland, J. H., Montello, M., Geoghegan, C., Abernethy, A. P., Clauser, S. B., Castro, K., Mitchell, S. A., Burke, L., Trentacosti, A. M., & Basch, E. M. (2011). Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Translational behavioral medicine, 1(1), 110-22. https://doi.org/10.1007/s13142-011-0025-3
Bruner, Deborah Watkins, et al. "Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)." Translational behavioral medicine vol. 1,1 (2011): 110-22. doi: https://doi.org/10.1007/s13142-011-0025-3
Bruner DW, Hanisch LJ, Reeve BB, Trotti AM, Schrag D, Sit L, Mendoza TR, Minasian L, O'Mara A, Denicoff AM, Rowland JH, Montello M, Geoghegan C, Abernethy AP, Clauser SB, Castro K, Mitchell SA, Burke L, Trentacosti AM, Basch EM. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med. 2011 Mar;1(1):110-22. doi: 10.1007/s13142-011-0025-3. PMID: 24073038; PMCID: PMC3717706.
Copy Download .nbib Format: NLM
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study.

Advances in radiation oncology

Falchook AD, Tracton G, Stravers L, Fleming ME, Snavely AC, Noe JF, Hayes DN, Grilley-Olson JE, Weiss JM, Reeve BB, Basch EM, Chera BS.
PMID: 28740878
Adv Radiat Oncol. 2016 Feb 18;1(2):115-121. doi: 10.1016/j.adro.2016.02.001. eCollection 2016.

PURPOSE: Accurate assessment of toxicity allows for timely delivery of supportive measures during radiation therapy for head and neck cancer. The current paradigm requires weekly evaluation of patients by a provider. The purpose of this study is to evaluate...

Cite
Falchook AD, Tracton G, Stravers L, et al. Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study. Adv Radiat Oncol. 2016;1(2):115-121doi: 10.1016/j.adro.2016.02.001.
Falchook, A. D., Tracton, G., Stravers, L., Fleming, M. E., Snavely, A. C., Noe, J. F., Hayes, D. N., Grilley-Olson, J. E., Weiss, J. M., Reeve, B. B., Basch, E. M., & Chera, B. S. (2016). Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study. Advances in radiation oncology, 1(2), 115-121. https://doi.org/10.1016/j.adro.2016.02.001
Falchook, Aaron D, et al. "Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study." Advances in radiation oncology vol. 1,2 (2016): 115-121. doi: https://doi.org/10.1016/j.adro.2016.02.001
Falchook AD, Tracton G, Stravers L, Fleming ME, Snavely AC, Noe JF, Hayes DN, Grilley-Olson JE, Weiss JM, Reeve BB, Basch EM, Chera BS. Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study. Adv Radiat Oncol. 2016 Feb 18;1(2):115-121. doi: 10.1016/j.adro.2016.02.001. eCollection 2016. PMID: 28740878; PMCID: PMC5506718.
Copy Download .nbib Format: NLM
Sediment Microbial Communities Influenced by Cool Hydrothermal Fluid Migration.

Frontiers in microbiology

Zinke LA, Reese BK, McManus J, Wheat CG, Orcutt BN, Amend JP.
PMID: 29951048
Front Microbiol. 2018 Jun 13;9:1249. doi: 10.3389/fmicb.2018.01249. eCollection 2018.

Cool hydrothermal systems (CHSs) are prevalent across the seafloor and discharge fluid volumes that rival oceanic input from rivers, yet the microbial ecology of these systems are poorly constrained. The Dorado Outcrop on the ridge flank of the Cocos...

Cite
Zinke LA, Reese BK, McManus J, et al. Sediment Microbial Communities Influenced by Cool Hydrothermal Fluid Migration. Front Microbiol. 2018;9:1249doi: 10.3389/fmicb.2018.01249.
Zinke, L. A., Reese, B. K., McManus, J., Wheat, C. G., Orcutt, B. N., & Amend, J. P. (2018). Sediment Microbial Communities Influenced by Cool Hydrothermal Fluid Migration. Frontiers in microbiology, 91249. https://doi.org/10.3389/fmicb.2018.01249
Zinke, Laura A, et al. "Sediment Microbial Communities Influenced by Cool Hydrothermal Fluid Migration." Frontiers in microbiology vol. 9 (2018): 1249. doi: https://doi.org/10.3389/fmicb.2018.01249
Zinke LA, Reese BK, McManus J, Wheat CG, Orcutt BN, Amend JP. Sediment Microbial Communities Influenced by Cool Hydrothermal Fluid Migration. Front Microbiol. 2018 Jun 13;9:1249. doi: 10.3389/fmicb.2018.01249. eCollection 2018. PMID: 29951048; PMCID: PMC6008377.
Copy Download .nbib Format: NLM
Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds.

Cell medicine

Dickerson JE, Planz JV, Reece BT, Weedon KA, Kirkpatrick SD, Slade HB.
PMID: 26858859
Cell Med. 2012 Oct 03;4(3):149-52. doi: 10.3727/215517912X653346. eCollection 2013 Mar.

HP802-247 is a living cell suspension of cultured allogeneic growth-arrested human male keratinocytes and fibroblasts (1:9 ratio), intended for spray application to chronic wounds. In this study, a small wound was created on the arms of 28 healthy female...

Cite
Dickerson JE, Planz JV, Reece BT, et al. Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds. Cell Med. 2012;4(3):149-52doi: 10.3727/215517912X653346.
Dickerson, J. E., Planz, J. V., Reece, B. T., Weedon, K. A., Kirkpatrick, S. D., & Slade, H. B. (2013). Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds. Cell medicine, 4(3), 149-52. https://doi.org/10.3727/215517912X653346
Dickerson, Jaime E, et al. "Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds." Cell medicine vol. 4,3 (2013): 149-52. doi: https://doi.org/10.3727/215517912X653346
Dickerson JE, Planz JV, Reece BT, Weedon KA, Kirkpatrick SD, Slade HB. Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds. Cell Med. 2012 Oct 03;4(3):149-52. doi: 10.3727/215517912X653346. eCollection 2013 Mar. PMID: 26858859; PMCID: PMC4733847.
Copy Download .nbib Format: NLM
Creatinine elevations from baseline at the time of cardiac surgery are associated with postoperative complications.

The Journal of thoracic and cardiovascular surgery

Griffin BR, Bronsert M, Reece TB, Pal JD, Cleveland JC, Fullerton DA, Faubel S, Aftab M.
PMID: 32739165
J Thorac Cardiovasc Surg. 2020 Jun 26; doi: 10.1016/j.jtcvs.2020.03.174. Epub 2020 Jun 26.

OBJECTIVES: Baseline kidney function is a key predictor of postoperative morbidity and mortality. Whether an increased creatinine at the time of surgery, compared with the lowest creatinine in the 3 months before surgery, is associated with poor outcomes has...

Cite
Griffin BR, Bronsert M, Reece TB, et al. Creatinine elevations from baseline at the time of cardiac surgery are associated with postoperative complications. J Thorac Cardiovasc Surg. 2020;doi: 10.1016/j.jtcvs.2020.03.174.
Griffin, B. R., Bronsert, M., Reece, T. B., Pal, J. D., Cleveland, J. C., Fullerton, D. A., Faubel, S., & Aftab, M. (2020). Creatinine elevations from baseline at the time of cardiac surgery are associated with postoperative complications. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2020.03.174
Griffin, Benjamin R, et al. "Creatinine elevations from baseline at the time of cardiac surgery are associated with postoperative complications." The Journal of thoracic and cardiovascular surgery vol. (2020). doi: https://doi.org/10.1016/j.jtcvs.2020.03.174
Griffin BR, Bronsert M, Reece TB, Pal JD, Cleveland JC, Fullerton DA, Faubel S, Aftab M. Creatinine elevations from baseline at the time of cardiac surgery are associated with postoperative complications. J Thorac Cardiovasc Surg. 2020 Jun 26; doi: 10.1016/j.jtcvs.2020.03.174. Epub 2020 Jun 26. PMID: 32739165; PMCID: PMC7762739.
Copy Download .nbib Format: NLM
Commentary: Size matters, but not as much as surgeon preference.

The Journal of thoracic and cardiovascular surgery

Wojcik BM, Reece TB.
PMID: 33712242
J Thorac Cardiovasc Surg. 2021 Feb 16; doi: 10.1016/j.jtcvs.2021.02.022. Epub 2021 Feb 16.

No abstract available.

Cite
Wojcik BM, Reece TB. Commentary: Size matters, but not as much as surgeon preference. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.02.022.
Wojcik, B. M., & Reece, T. B. (2021). Commentary: Size matters, but not as much as surgeon preference. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.02.022
Wojcik, Brandon M, and Reece, T Brett. "Commentary: Size matters, but not as much as surgeon preference." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.02.022
Wojcik BM, Reece TB. Commentary: Size matters, but not as much as surgeon preference. J Thorac Cardiovasc Surg. 2021 Feb 16; doi: 10.1016/j.jtcvs.2021.02.022. Epub 2021 Feb 16. PMID: 33712242.
Copy Download .nbib Format: NLM
Comparison of PROMIS.

Arthritis care & research

Patel RN, Esparza VG, Lai JS, Gray EL, Reeve BB, Chang RW, Cella D, Ardalan K.
PMID: 34328696
Arthritis Care Res (Hoboken). 2021 Jul 30; doi: 10.1002/acr.24760. Epub 2021 Jul 30.

OBJECTIVE: Patient-Reported Outcomes Measurement Information SystemMETHODS: Patients 8-17 yo (self-report and parent proxy) and parents of patients 5-7 yo (only parent proxy) completed PROMIS Fatigue, Pain Interference, Upper Extremity Function, Mobility, Anxiety and Depressive Symptoms measures. Pearson correlations, paired...

Cite
Patel RN, Esparza VG, Lai JS, et al. Comparison of PROMIS. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24760.
Patel, R. N., Esparza, V. G., Lai, J. S., Gray, E. L., Reeve, B. B., Chang, R. W., Cella, D., & Ardalan, K. (2021). Comparison of PROMIS. Arthritis care & research, . https://doi.org/10.1002/acr.24760
Patel, Ruchi N, et al. "Comparison of PROMIS." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24760
Patel RN, Esparza VG, Lai JS, Gray EL, Reeve BB, Chang RW, Cella D, Ardalan K. Comparison of PROMIS. Arthritis Care Res (Hoboken). 2021 Jul 30; doi: 10.1002/acr.24760. Epub 2021 Jul 30. PMID: 34328696.
Copy Download .nbib Format: NLM
"If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.

Digestive diseases and sciences

Evon DM, Kim HP, Edwards A, Carda-Auten J, Reeve BB, Golin CE, Fried MW.
PMID: 33528686
Dig Dis Sci. 2022 Jan;67(1):100-120. doi: 10.1007/s10620-021-06829-2. Epub 2021 Feb 02.

BACKGROUND: Patients' motivations for undergoing direct-acting antiviral (DAA) therapy for chronic hepatitis C may include anticipation of treatment benefits not well described in the literature.AIMS: Evaluate patients' anticipated and actualized improvements in several domains of functioning before and after...

Cite
Evon DM, Kim HP, Edwards A, et al. "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C. Dig Dis Sci. 2021;67(1):100-120doi: 10.1007/s10620-021-06829-2.
Evon, D. M., Kim, H. P., Edwards, A., Carda-Auten, J., Reeve, B. B., Golin, C. E., & Fried, M. W. (2022). "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C. Digestive diseases and sciences, 67(1), 100-120. https://doi.org/10.1007/s10620-021-06829-2
Evon, Donna M, et al. ""If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C." Digestive diseases and sciences vol. 67,1 (2022): 100-120. doi: https://doi.org/10.1007/s10620-021-06829-2
Evon DM, Kim HP, Edwards A, Carda-Auten J, Reeve BB, Golin CE, Fried MW. "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C. Dig Dis Sci. 2022 Jan;67(1):100-120. doi: 10.1007/s10620-021-06829-2. Epub 2021 Feb 02. PMID: 33528686; PMCID: PMC8326296.
Copy Download .nbib Format: NLM
Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society

Chen C, Mossman E, Malko P, McDonald D, Blain AP, Bone L, Erskine D, Filby A, Vincent AE, Hudson G, Reeve AK.
PMID: 34779538
Mov Disord. 2021 Nov 15; doi: 10.1002/mds.28849. Epub 2021 Nov 15.

BACKGROUND: Mitochondrial dysfunction within neurons, particularly those of the substantia nigra, has been well characterized in Parkinson's disease and is considered to be related to the pathogenesis of this disorder. Dysfunction within this important organelle has been suggested to...

Cite
Chen C, Mossman E, Malko P, et al. Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Mov Disord. 2021;doi: 10.1002/mds.28849.
Chen, C., Mossman, E., Malko, P., McDonald, D., Blain, A. P., Bone, L., Erskine, D., Filby, A., Vincent, A. E., Hudson, G., & Reeve, A. K. (2021). Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, . https://doi.org/10.1002/mds.28849
Chen, Chun, et al. "Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease." Movement disorders : official journal of the Movement Disorder Society vol. (2021). doi: https://doi.org/10.1002/mds.28849
Chen C, Mossman E, Malko P, McDonald D, Blain AP, Bone L, Erskine D, Filby A, Vincent AE, Hudson G, Reeve AK. Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Mov Disord. 2021 Nov 15; doi: 10.1002/mds.28849. Epub 2021 Nov 15. PMID: 34779538.
Copy Download .nbib Format: NLM
The prevalence and risk of symptom and function clusters in colorectal cancer survivors.

Journal of cancer survivorship : research and practice

Potosky AL, Graves KD, Lin L, Pan W, Fall-Dickson JM, Ahn J, Ferguson KM, Keegan THM, Paddock LE, Wu XC, Cress R, Reeve BB.
PMID: 34787775
J Cancer Surviv. 2021 Nov 17; doi: 10.1007/s11764-021-01123-6. Epub 2021 Nov 17.

PURPOSE: Our purpose was to describe the prevalence and predictors of symptom and function clusters in a diverse cohort of colorectal cancer survivors.METHODS: We used data from a cohort of 909 adult colorectal cancer survivors. Participants were surveyed at...

Cite
Potosky AL, Graves KD, Lin L, et al. The prevalence and risk of symptom and function clusters in colorectal cancer survivors. J Cancer Surviv. 2021;doi: 10.1007/s11764-021-01123-6.
Potosky, A. L., Graves, K. D., Lin, L., Pan, W., Fall-Dickson, J. M., Ahn, J., Ferguson, K. M., Keegan, T. H. M., Paddock, L. E., Wu, X. C., Cress, R., & Reeve, B. B. (2021). The prevalence and risk of symptom and function clusters in colorectal cancer survivors. Journal of cancer survivorship : research and practice, . https://doi.org/10.1007/s11764-021-01123-6
Potosky, Arnold L, et al. "The prevalence and risk of symptom and function clusters in colorectal cancer survivors." Journal of cancer survivorship : research and practice vol. (2021). doi: https://doi.org/10.1007/s11764-021-01123-6
Potosky AL, Graves KD, Lin L, Pan W, Fall-Dickson JM, Ahn J, Ferguson KM, Keegan THM, Paddock LE, Wu XC, Cress R, Reeve BB. The prevalence and risk of symptom and function clusters in colorectal cancer survivors. J Cancer Surviv. 2021 Nov 17; doi: 10.1007/s11764-021-01123-6. Epub 2021 Nov 17. PMID: 34787775.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 194 entries